欢迎来到天天文库
浏览记录
ID:55683783
大小:265.67 KB
页数:3页
时间:2020-05-24
《超选择性肝动脉栓塞治疗多囊肝的长期疗效观察.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、·134·中华临床医师杂志f电子~)2013年12月第7卷第24靓ChinCliniciansfE1ectronicEdition).December15.2013.v0l_7.No.24临床论著超选择性肝动脉栓塞治疗多囊肝的长期疗效观察常中飞袁凯王茂强刘凤永段峰阎洁羽【摘要】目的评价用超选择性肝动脉栓塞术(TAE)治疗多囊肝(PLD)的长期疗效和安全性。方法对23例有严重症状的PLD患者进行超选择性肝动脉栓塞术。患者女l9例,男4例,年龄36.O~68.0岁,平均(49.3±3.4)岁。所有患者在TAE前后行上腹部CT平扫+增强扫描:TAE后第3个月、第6个月及此后每间隔半年复
2、查CT。结果23例患者共行27次介入治疗,手术技术成功率为100%,中位随访时间为19个月(3~58个月),2例无效,可供评价疗效者21例,有效率为91.2%。术前患者平均腹围为(1O5.7±8.1)cm,术后患者平均腹围为(95.2±6.7)cm,术前术后平均腹围具有统计学差异(P3、肝Thesafetyandlong-termeficiencyoftranscathetersuper-selectivehepaticarterialembolizationfortreatmentwithpolycysticfiverdiseaseCHANGZhong-fei;YUANKai,NGMao-qiang,LIUFeng-yong,DUANFeng,YANJie-yu.*DepartmentofOncology,BeijingShijingshanHospital,ShijingshanTeachingHospitalofCapitalMedicalUniversi4、ty,Beijing100043,ChinaCorrespondingauthor:WANGMao-qiang,Email:wangmq@vip.sina.com[Abstract]ObjectiveToevaluatethesafetyandlong-termeficacyoftranscathetersuper—selectivehepaticarterialembolization(TAE)forpatientswithpolycysticliverdiseasefPLD).MethodsAtotalof23patientswithsymptomaticPLDwereenr5、olled.epatientsconsistedofnineteenwomenandfourmen[aged36.O一68.0years,meanage(49.3±3.4)years].Allpatientsunderwentcontrastenhancedcomputedtomography(CT)scanoftheliverbeforeTAEandatevery3monthsforthefirsthalfyearafterTAE,andat6-monthlyintervalsthereafter.ResultsFollow-upwasperformedatamedianof16、9months(range3-58months).23casesweretreatedbyintervention27times.AllprocedureswereSuccessfu1withoutseriouscomplications.TAEfailedtobenefitin2patients,buttherewerenocomplaintsofworseningofthesymptoms.availablefor21patientsevaluableforeficacy,efectiverateof91.2%.Theaveragepreoperativeabdominalc7、ircumferencewas(105.7±8.1)cm.theaveragepostoperativeabdominalcircumferencewas(95.2±6.7)cm.Aftertreatmentaverageabdominalcircumferencereduction10.1cm(3.0-21.0cm),statisticallysignificant(P<0.001).Aftertreatmentaverageabdominalcircumferencebega
3、肝Thesafetyandlong-termeficiencyoftranscathetersuper-selectivehepaticarterialembolizationfortreatmentwithpolycysticfiverdiseaseCHANGZhong-fei;YUANKai,NGMao-qiang,LIUFeng-yong,DUANFeng,YANJie-yu.*DepartmentofOncology,BeijingShijingshanHospital,ShijingshanTeachingHospitalofCapitalMedicalUniversi
4、ty,Beijing100043,ChinaCorrespondingauthor:WANGMao-qiang,Email:wangmq@vip.sina.com[Abstract]ObjectiveToevaluatethesafetyandlong-termeficacyoftranscathetersuper—selectivehepaticarterialembolization(TAE)forpatientswithpolycysticliverdiseasefPLD).MethodsAtotalof23patientswithsymptomaticPLDwereenr
5、olled.epatientsconsistedofnineteenwomenandfourmen[aged36.O一68.0years,meanage(49.3±3.4)years].Allpatientsunderwentcontrastenhancedcomputedtomography(CT)scanoftheliverbeforeTAEandatevery3monthsforthefirsthalfyearafterTAE,andat6-monthlyintervalsthereafter.ResultsFollow-upwasperformedatamedianof1
6、9months(range3-58months).23casesweretreatedbyintervention27times.AllprocedureswereSuccessfu1withoutseriouscomplications.TAEfailedtobenefitin2patients,buttherewerenocomplaintsofworseningofthesymptoms.availablefor21patientsevaluableforeficacy,efectiverateof91.2%.Theaveragepreoperativeabdominalc
7、ircumferencewas(105.7±8.1)cm.theaveragepostoperativeabdominalcircumferencewas(95.2±6.7)cm.Aftertreatmentaverageabdominalcircumferencereduction10.1cm(3.0-21.0cm),statisticallysignificant(P<0.001).Aftertreatmentaverageabdominalcircumferencebega
此文档下载收益归作者所有